- Home
- SGMT vs SJT Comparison
SGMT vs SJT Comparison
Compare SGMT & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- SJT
- Stock Information
- Founded
- SGMT 2006
- SJT 1980
- Country
- SGMT United States
- SJT United States
- Employees
- SGMT N/A
- SJT N/A
- Industry
- SGMT
- SJT Oil & Gas Production
- Sector
- SGMT
- SJT Energy
- Exchange
- SGMT Nasdaq
- SJT Nasdaq
- Market Cap
- SGMT 269.2M
- SJT 281.5M
- IPO Year
- SGMT 2023
- SJT N/A
- Fundamental
- Price
- SGMT $8.11
- SJT $6.12
- Analyst Decision
- SGMT Strong Buy
- SJT
- Analyst Count
- SGMT 5
- SJT 0
- Target Price
- SGMT $26.60
- SJT N/A
- AVG Volume (30 Days)
- SGMT 3.5M
- SJT 237.7K
- Earning Date
- SGMT 08-13-2025
- SJT 08-13-2025
- Dividend Yield
- SGMT N/A
- SJT N/A
- EPS Growth
- SGMT N/A
- SJT N/A
- EPS
- SGMT N/A
- SJT 0.02
- Revenue
- SGMT N/A
- SJT $1,931,777.00
- Revenue This Year
- SGMT N/A
- SJT N/A
- Revenue Next Year
- SGMT N/A
- SJT N/A
- P/E Ratio
- SGMT N/A
- SJT $270.29
- Revenue Growth
- SGMT N/A
- SJT N/A
- 52 Week Low
- SGMT $1.73
- SJT $3.21
- 52 Week High
- SGMT $10.43
- SJT $7.22
- Technical
- Relative Strength Index (RSI)
- SGMT 60.20
- SJT 48.03
- Support Level
- SGMT $7.51
- SJT $6.28
- Resistance Level
- SGMT $8.61
- SJT $6.25
- Average True Range (ATR)
- SGMT 1.32
- SJT 0.30
- MACD
- SGMT -0.10
- SJT -0.03
- Stochastic Oscillator
- SGMT 47.92
- SJT 38.46
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.